Form 8-K - Current report:
SEC Accession No. 0000912282-15-000380
Filing Date
2015-09-30
Accepted
2015-09-30 12:11:55
Documents
32
Period of Report
2015-09-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_09292015.htm 8-K 26596
2 INVESTOR PRESENTATION ex99_1.htm EX-99.1 27166
3 slide1.jpg GRAPHIC 25366
4 slide2.jpg GRAPHIC 187288
5 slide3.jpg GRAPHIC 87406
6 slide4.jpg GRAPHIC 53260
7 slide5.jpg GRAPHIC 101495
8 slide6.jpg GRAPHIC 24328
9 slide7.jpg GRAPHIC 108678
10 slide8.jpg GRAPHIC 107426
11 slide9.jpg GRAPHIC 112321
12 slide10.jpg GRAPHIC 123993
13 slide11.jpg GRAPHIC 92168
14 slide12.jpg GRAPHIC 105144
15 slide13.jpg GRAPHIC 98998
16 slide14.jpg GRAPHIC 88467
17 slide15.jpg GRAPHIC 112906
18 slide16.jpg GRAPHIC 109418
19 slide17.jpg GRAPHIC 116860
20 slide18.jpg GRAPHIC 108413
21 slide19.jpg GRAPHIC 104323
22 slide20.jpg GRAPHIC 24819
23 slide21.jpg GRAPHIC 74969
24 slide22.jpg GRAPHIC 96567
25 slide23.jpg GRAPHIC 57554
26 slide24.jpg GRAPHIC 113207
27 slide25.jpg GRAPHIC 91134
28 slide26.jpg GRAPHIC 48314
29 slide27.jpg GRAPHIC 67017
30 slide28.jpg GRAPHIC 147701
31 slide29.jpg GRAPHIC 137210
32 slide30.jpg GRAPHIC 45685
  Complete submission text file 0000912282-15-000380.txt   3875870
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 151133146
SIC: 2834 Pharmaceutical Preparations